[go: up one dir, main page]

MX2016010022A - Pharmaceutical composition of amfepramone and topiramate useful in the overweight and obesity treatment. - Google Patents

Pharmaceutical composition of amfepramone and topiramate useful in the overweight and obesity treatment.

Info

Publication number
MX2016010022A
MX2016010022A MX2016010022A MX2016010022A MX2016010022A MX 2016010022 A MX2016010022 A MX 2016010022A MX 2016010022 A MX2016010022 A MX 2016010022A MX 2016010022 A MX2016010022 A MX 2016010022A MX 2016010022 A MX2016010022 A MX 2016010022A
Authority
MX
Mexico
Prior art keywords
amfepramone
topiramate
overweight
useful
pharmaceutical composition
Prior art date
Application number
MX2016010022A
Other languages
Spanish (es)
Other versions
MX373380B (en
Inventor
FERNÁNDEZ DEL VALLE LAISEQUILLA Cecilia
Issac Rocha González Héctor
URBINA CHÁVEZ Miguel
Antonio Ramírez Ochoa Juan
Gerardo REYES GARCÍA Juan
Original Assignee
Productos Medix S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Productos Medix S A De C V filed Critical Productos Medix S A De C V
Priority to MX2016010022A priority Critical patent/MX373380B/en
Publication of MX2016010022A publication Critical patent/MX2016010022A/en
Publication of MX373380B publication Critical patent/MX373380B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención describe combinaciones y composiciones farmacéuticas que comprenden cantidades terapéuticamente efectivas de amfepramona y topiramato, y su uso en la preparación de medicamentos útiles en el tratamiento de sobrepeso y obesidad.The present invention describes combinations and pharmaceutical compositions comprising therapeutically effective amounts of amfepramone and topiramate, and their use in the preparation of medicaments useful in the treatment of overweight and obesity.

MX2016010022A 2016-08-02 2016-08-02 PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY. MX373380B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2016010022A MX373380B (en) 2016-08-02 2016-08-02 PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016010022A MX373380B (en) 2016-08-02 2016-08-02 PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY.

Publications (2)

Publication Number Publication Date
MX2016010022A true MX2016010022A (en) 2016-11-10
MX373380B MX373380B (en) 2020-07-02

Family

ID=58161033

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010022A MX373380B (en) 2016-08-02 2016-08-02 PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY.

Country Status (1)

Country Link
MX (1) MX373380B (en)

Also Published As

Publication number Publication date
MX373380B (en) 2020-07-02

Similar Documents

Publication Publication Date Title
SV2018005610A (en) SUBSTITUTED OXOPIRIDINE DERIVATIVES
MX383164B (en) COMPOSITION CONTAINING RNA FOR THE TREATMENT OF TUMOR DISEASES.
CL2016001609A1 (en) Pharmaceutical compositions comprising azd9291.
BR112015024411A2 (en) macrocyclic desaza purinones for the treatment of viral infections
CO2019008103A2 (en) Pharmaceutical compositions for combination therapy
MX2019012847A (en) C5-anilinoquinazoline compounds and their use in treating cancer.
MX2019015124A (en) Composition comprising mannose oligosaccharide and process for making same and use thereof.
MX2021004566A (en) THERAPEUTIC COMPOUNDS.
CL2015000039A1 (en) Estra-1,3,5 (10), 16-tetraeno-3-substituted derivatives, pharmaceutical preparations that comprise them and their use in the preparation of medicaments for treating endometriosis.
MX2021010041A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING PROTEIN KINASE AKT INHIBITORS.
MX2019012522A (en) COMPOUNDS AND THERAPEUTIC METHODS.
UY37729A (en) NEW COMPOUNDS THAT INHIBIT THE ACTIVITY OF Nav1.7
UY37622A (en) PIRAZOL DERIVATIVES AS BET FAMILY BROMODOMINAL INHIBITORS AND THEIR USE IN THERAPEUTIC APPLICATIONS
CL2021000930A1 (en) Novel Pyridazines
CL2017000884A1 (en) Pharmaceutical composition for use in the treatment or prevention of vitamin and mineral deficiencies in patients who have undergone gastric bypass surgery
MX2017011904A (en) COMPOSITIONS FOR THE TREATMENT OF FIBROSIS AND AFFECTIONS RELATED TO FIBROSIS.
CO2019007671A2 (en) A pharmaceutical composition comprising an oxazine derivative and its use in the treatment or prevention of Alzheimer's disease
MX2019009909A (en) Pharmaceutical compositions for combination therapy.
MX2016010022A (en) Pharmaceutical composition of amfepramone and topiramate useful in the overweight and obesity treatment.
DOP2019000052A (en) THESOFENSINE COMPOSITIONS
MX384394B (en) COMPOUND FOR USE IN THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES.
CL2016001054A1 (en) Compounds for the treatment of diabetes and complications of diseases derived from it
MX386783B (en) PEPTIDOMIMETIC COMPOUNDS THAT NEUTRALIZE THE INFLUENZA VIRUS.
EA201791483A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MYCOSIS
BR112018076014A2 (en) compositions comprising timolol and their use in the treatment of rosacea by topical administration

Legal Events

Date Code Title Description
FG Grant or registration